Cite
MLA Citation
W.S. Kim et al.. “AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA.” Hematological oncology, vol. 37, n.d., pp. 567–568. http://access.bl.uk/ark:/81055/vdc_100086208786.0x00003f